Circulating extracellular DNA is in association with continuous metabolic syndrome score in healthy adolescents

Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin...

Full description

Saved in:
Bibliographic Details
Published inPhysiological genomics Vol. 53; no. 7; pp. 309 - 318
Main Authors Celec, Peter, Janovičová, Ĺubica, Gurecká, Radana, Koborová, Ivana, Gardlík, Roman, Šebeková, Katarína
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.07.2021
Subjects
Online AccessGet full text
ISSN1094-8341
1531-2267
1531-2267
DOI10.1152/physiolgenomics.00029.2021

Cover

Abstract Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents ( n = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11–21) vs. 11 (8–17) ng/mL; median (interquartile range)], nuclear [1,760 (956–3,273) vs. 1,153 (600–2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836–90,896) vs. 30,089 (12,587–72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score ( r = 0.158 for males and r = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP ( r = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome.
AbstractList Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents ( n = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11–21) vs. 11 (8–17) ng/mL; median (interquartile range)], nuclear [1,760 (956–3,273) vs. 1,153 (600–2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836–90,896) vs. 30,089 (12,587–72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score ( r = 0.158 for males and r = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP ( r = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome.
Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents ( = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11-21) vs. 11 (8-17) ng/mL; median (interquartile range)], nuclear [1,760 (956-3,273) vs. 1,153 (600-2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836-90,896) vs. 30,089 (12,587-72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score ( = 0.158 for males and = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP ( = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome.
Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents (n = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11-21) vs. 11 (8-17) ng/mL; median (interquartile range)], nuclear [1,760 (956-3,273) vs. 1,153 (600-2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836-90,896) vs. 30,089 (12,587-72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score (r = 0.158 for males and r = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP (r = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome.Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized that ecDNA, especially of mitochondrial origin, could be associated with components of the metabolic syndrome in young healthy probands. In a cross-sectional study, healthy adolescents (n = 1,249) provided blood samples. Anthropometric data, blood pressure, and blood counts were assessed. In addition, biochemical analysis of sera or plasma was conducted, including the quantification of advanced oxidation protein products (AOPPs) as a marker of oxidative stress induced by neutrophil or monocyte activation. Plasma ecDNA was isolated and measured by fluorometry. Nuclear and mitochondrial DNA were quantified by real-time PCR. Males had higher total plasma ecDNA [15 (11-21) vs. 11 (8-17) ng/mL; median (interquartile range)], nuclear [1,760 (956-3,273) vs. 1,153 (600-2,292) genome equivalents (GE)/mL], and mitochondrial [37,181 (14,836-90,896) vs. 30,089 (12,587-72,286) GE/mL] DNA. ecDNA correlated positively with the continuous metabolic syndrome score (r = 0.158 for males and r = 0.134 for females). Stronger correlations were found between ecDNA of mitochondrial origin and AOPP (r = 0.202 and 0.186 for males and females, respectively). Multivariate regression analysis revealed associations of nuclear DNA with leukocyte and erythrocyte counts. The results of this study of healthy adolescents show that circulating ecDNA is associated with the risk of metabolic syndrome, not with obesity per se. The association between mitochondrial ecDNA and AOPP requires further attention as it supports a potential role of mitochondria-induced sterile inflammation in the pathogenesis of the metabolic syndrome.
Author Šebeková, Katarína
Janovičová, Ĺubica
Gardlík, Roman
Koborová, Ivana
Celec, Peter
Gurecká, Radana
Author_xml – sequence: 1
  givenname: Peter
  orcidid: 0000-0001-5883-3580
  surname: Celec
  fullname: Celec, Peter
  organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia, Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia, Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia
– sequence: 2
  givenname: Ĺubica
  surname: Janovičová
  fullname: Janovičová, Ĺubica
  organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
– sequence: 3
  givenname: Radana
  surname: Gurecká
  fullname: Gurecká, Radana
  organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia, Institute of Medical Physics, Biophysics, Informatics and Telemedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
– sequence: 4
  givenname: Ivana
  surname: Koborová
  fullname: Koborová, Ivana
  organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
– sequence: 5
  givenname: Roman
  surname: Gardlík
  fullname: Gardlík, Roman
  organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia, Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
– sequence: 6
  givenname: Katarína
  orcidid: 0000-0002-9641-9265
  surname: Šebeková
  fullname: Šebeková, Katarína
  organization: Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34097532$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtvFDEQhC0URJKFv4AsuHCZxY_xPDgRLY8gReQSzqMe25N15LEXt0dh_z3eJHDYUy62ZX3Vqq46JychBkvIO87WnCvxcbfdo4v-1oY4O41rxpjo14IJ_oKccSV5JUTTnpQ36-uqkzU_JeeId4zxuu3UK3Iqa9a3SoozEjcu6cVDduGW2j85gbbel49Ev_y8oA6pCxQQo3aFiYHeu7ylOoYiWOKCdLYZxuidprgPJsXZUtQx2YNua8Hn7Z6Cid6itiHja_JyAo_2zdO9Ir--fb3ZXFZX199_bC6uKi3rNlcc6lZC24Eei_2-NiOrG6N7NXLTKNMIDdpwU_aEqWnASmMAJO-nvpuMajq5Ih8e5-5S_L1YzMPs8LAaBFtsD0LJXrC2HAV9f4TexSWF4q5QquOqUyXUFXn7RC3jbM2wS26GtB_-RVmAT4-AThEx2ek_wtlw6G046m146G049FbEn4_E2uWHwEsjzj9nxF8lU6j4
CitedBy_id crossref_primary_10_1007_s11357_022_00590_8
crossref_primary_10_3390_nu17020241
crossref_primary_10_1111_obr_13674
crossref_primary_10_1038_s41598_025_86857_4
crossref_primary_10_3390_biomedicines13020502
crossref_primary_10_3390_biomedicines11092514
crossref_primary_10_1038_s41598_023_28903_7
crossref_primary_10_4240_wjgs_v14_i9_887
Cites_doi 10.1016/j.jtcvs.2018.09.043
10.1084/jem.20120201
10.7754/clin.lab.2015.141239
10.1016/j.diabet.2018.06.004
10.1016/j.atherosclerosis.2013.12.022
10.1385/ENDO:13:2:155
10.1016/j.clim.2012.04.006
10.1038/nm.3887
10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
10.2337/dc06-134
10.1111/j.1399-5448.2007.00271.x
10.1038/s41598-019-41593-4
10.1007/s10522-019-09808-3
10.1073/pnas.1500076112
10.1016/j.biopha.2017.06.009
10.1007/s10096-016-2805-7
10.1182/bloodadvances.2018018895
10.1038/nrg2468
10.1038/s41598-020-70526-9
10.1111/acel.12890
10.4049/jimmunol.161.5.2524
10.1373/clinchem.2017.272401
10.1007/s10555-016-9629-x
10.1097/SHK.0000000000001215
10.1373/clinchem.2007.101030
10.1186/s12916-014-0207-1
10.1038/oby.2012.138
10.1093/ndt/gfv454
10.1093/clinchem/48.3.421
10.1017/erm.2017.12
10.4049/jimmunol.1201719
10.1371/journal.pone.0069805
10.1186/s13054-018-2109-7
10.1186/1755-8794-7-54
10.1016/j.ajhg.2020.01.008
10.1186/s40246-019-0244-0
10.1097/MED.0b013e3282f43d19
10.1152/ajpgi.00446.2016
10.1073/pnas.1815031116
10.3390/ijms21218062
10.3389/fmed.2020.593316
10.1016/j.numecd.2015.11.008
10.1161/01.CIR.0000111245.75752.C6
10.15252/embr.201949799
10.1038/s41467-018-07466-6
10.1126/science.abe7199
10.1007/s00592-019-01471-x
10.1373/clinchem.2013.203679
10.1111/j.1467-789X.2009.00674.x
10.1002/pd.3919
10.1007/s00414-019-02240-9
10.1126/sciadv.1501332
10.1038/s41598-020-72393-w
10.1371/journal.pone.0039853
10.1136/bmjdrc-2020-001372
10.1371/journal.pone.0223470
10.1373/clinchem.2018.298323
10.1186/s41232-020-00118-7
10.1016/j.bcp.2010.01.013
10.21101/cejph.a4968
10.1126/science.1092385
10.1016/j.annepidem.2010.08.001
10.1159/000510088
10.1038/nature08780
10.7754/clin.lab.2014.141132
10.1146/annurev-immunol-031210-101322
10.3390/cells8040328
10.1161/CIRCULATIONAHA.105.169404
10.1371/journal.pone.0146143
10.1038/ki.1996.186
10.1097/SHK.0b013e3181cd8c08
10.1016/j.diabres.2008.04.002
10.3390/ijms20174163
10.1371/journal.pone.0129311
10.1038/s41598-020-74288-2
10.33549/physiolres.934242
10.3389/fphys.2019.01607
10.1186/1475-2840-7-17
ContentType Journal Article
Copyright Copyright American Physiological Society Jul 2021
Copyright_xml – notice: Copyright American Physiological Society Jul 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TM
8FD
FR3
P64
RC3
7X8
DOI 10.1152/physiolgenomics.00029.2021
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Engineering Research Database
Technology Research Database
Nucleic Acids Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1531-2267
EndPage 318
ExternalDocumentID 34097532
10_1152_physiolgenomics_00029_2021
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Slovakia
GeographicLocations_xml – name: Slovakia
GroupedDBID ---
123
29O
2WC
4.4
5VS
AAFWJ
AAYXX
ABHWK
ABJNI
ABKWE
ACGFS
ACPRK
ADBBV
ADFNX
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EMOBN
F5P
H13
ITBOX
KQ8
OK1
P2P
R.V
RAP
RHI
RPRKH
TR2
W8F
WOQ
XSW
CGR
CUY
CVF
ECM
EIF
NPM
7TM
8FD
FR3
P64
RC3
7X8
ID FETCH-LOGICAL-c347t-1a473a78acb34194db046dc95b1d65d62cacd1d226af66ae3ddaa319f98fd5683
ISSN 1094-8341
1531-2267
IngestDate Fri Jul 11 15:22:44 EDT 2025
Mon Jun 30 02:45:47 EDT 2025
Thu Apr 03 07:01:34 EDT 2025
Tue Jul 01 01:03:53 EDT 2025
Thu Apr 24 23:00:14 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords metabolic syndrome
cell-free DNA
microinflammation
obesity
observational study
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c347t-1a473a78acb34194db046dc95b1d65d62cacd1d226af66ae3ddaa319f98fd5683
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5883-3580
0000-0002-9641-9265
PMID 34097532
PQID 2558158515
PQPubID 2047828
PageCount 10
ParticipantIDs proquest_miscellaneous_2539207392
proquest_journals_2558158515
pubmed_primary_34097532
crossref_primary_10_1152_physiolgenomics_00029_2021
crossref_citationtrail_10_1152_physiolgenomics_00029_2021
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-07-01
20210701
PublicationDateYYYYMMDD 2021-07-01
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
PublicationTitle Physiological genomics
PublicationTitleAlternate Physiol Genomics
PublicationYear 2021
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
References B20
B64
B21
B65
B22
B66
B23
B67
B24
B68
B25
B69
B26
B27
B28
B29
B71
B73
B30
B74
B31
B75
B32
B76
B33
B77
B34
B78
B35
B79
B36
B37
B38
B39
Witko-Sarsat V (B70) 1998; 161
B1
B2
B3
B4
B5
B6
B7
B8
B9
B40
B41
B42
B43
B44
B45
B46
B47
B48
B49
B50
B51
B52
B53
B10
B54
B11
B55
B12
B56
B13
B57
B14
B58
B15
B59
B16
B17
B18
B19
B60
B61
B62
B63
References_xml – ident: B34
  doi: 10.1016/j.jtcvs.2018.09.043
– ident: B76
  doi: 10.1084/jem.20120201
– ident: B67
  doi: 10.7754/clin.lab.2015.141239
– ident: B39
  doi: 10.1016/j.diabet.2018.06.004
– ident: B57
  doi: 10.1016/j.atherosclerosis.2013.12.022
– ident: B1
  doi: 10.1385/ENDO:13:2:155
– ident: B11
  doi: 10.1016/j.clim.2012.04.006
– ident: B24
  doi: 10.1038/nm.3887
– ident: B25
  doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
– ident: B28
  doi: 10.2337/dc06-134
– ident: B27
  doi: 10.1111/j.1399-5448.2007.00271.x
– ident: B58
  doi: 10.1038/s41598-019-41593-4
– ident: B75
  doi: 10.1007/s10522-019-09808-3
– ident: B63
  doi: 10.1073/pnas.1500076112
– ident: B12
  doi: 10.1016/j.biopha.2017.06.009
– ident: B65
  doi: 10.1007/s10096-016-2805-7
– ident: B51
  doi: 10.1182/bloodadvances.2018018895
– ident: B4
  doi: 10.1038/nrg2468
– ident: B49
  doi: 10.1038/s41598-020-70526-9
– ident: B68
  doi: 10.1111/acel.12890
– volume: 161
  start-page: 2524
  year: 1998
  ident: B70
  publication-title: J Immunol
  doi: 10.4049/jimmunol.161.5.2524
– ident: B74
  doi: 10.1373/clinchem.2017.272401
– ident: B45
  doi: 10.1007/s10555-016-9629-x
– ident: B52
  doi: 10.1097/SHK.0000000000001215
– ident: B33
  doi: 10.1373/clinchem.2007.101030
– ident: B32
  doi: 10.1186/s12916-014-0207-1
– ident: B17
  doi: 10.1038/oby.2012.138
– ident: B37
  doi: 10.1093/ndt/gfv454
– ident: B10
  doi: 10.1093/clinchem/48.3.421
– ident: B35
  doi: 10.1017/erm.2017.12
– ident: B22
  doi: 10.4049/jimmunol.1201719
– ident: B64
  doi: 10.1371/journal.pone.0069805
– ident: B71
  doi: 10.1186/s13054-018-2109-7
– ident: B48
  doi: 10.1186/1755-8794-7-54
– ident: B61
  doi: 10.1016/j.ajhg.2020.01.008
– ident: B15
  doi: 10.1186/s40246-019-0244-0
– ident: B2
  doi: 10.1097/MED.0b013e3282f43d19
– ident: B13
  doi: 10.1152/ajpgi.00446.2016
– ident: B62
  doi: 10.1073/pnas.1815031116
– ident: B9
  doi: 10.3390/ijms21218062
– ident: B14
  doi: 10.3389/fmed.2020.593316
– ident: B23
  doi: 10.1016/j.numecd.2015.11.008
– ident: B3
  doi: 10.1161/01.CIR.0000111245.75752.C6
– ident: B53
  doi: 10.15252/embr.201949799
– ident: B73
  doi: 10.1038/s41467-018-07466-6
– ident: B59
  doi: 10.1126/science.abe7199
– ident: B40
  doi: 10.1007/s00592-019-01471-x
– ident: B66
  doi: 10.1373/clinchem.2013.203679
– ident: B5
  doi: 10.1111/j.1467-789X.2009.00674.x
– ident: B16
  doi: 10.1002/pd.3919
– ident: B69
  doi: 10.1007/s00414-019-02240-9
– ident: B18
  doi: 10.1126/sciadv.1501332
– ident: B20
  doi: 10.1038/s41598-020-72393-w
– ident: B44
  doi: 10.1371/journal.pone.0039853
– ident: B56
  doi: 10.1136/bmjdrc-2020-001372
– ident: B79
  doi: 10.1371/journal.pone.0223470
– ident: B78
  doi: 10.1373/clinchem.2018.298323
– ident: B8
  doi: 10.1186/s41232-020-00118-7
– ident: B77
  doi: 10.1016/j.bcp.2010.01.013
– ident: B47
  doi: 10.21101/cejph.a4968
– ident: B21
  doi: 10.1126/science.1092385
– ident: B30
  doi: 10.1016/j.annepidem.2010.08.001
– ident: B42
  doi: 10.1159/000510088
– ident: B54
  doi: 10.1038/nature08780
– ident: B43
  doi: 10.7754/clin.lab.2014.141132
– ident: B7
  doi: 10.1146/annurev-immunol-031210-101322
– ident: B41
  doi: 10.3390/cells8040328
– ident: B26
  doi: 10.1161/CIRCULATIONAHA.105.169404
– ident: B31
  doi: 10.1371/journal.pone.0146143
– ident: B38
  doi: 10.1038/ki.1996.186
– ident: B19
  doi: 10.1097/SHK.0b013e3181cd8c08
– ident: B46
  doi: 10.1016/j.diabres.2008.04.002
– ident: B60
  doi: 10.3390/ijms20174163
– ident: B36
  doi: 10.1371/journal.pone.0129311
– ident: B50
  doi: 10.1038/s41598-020-74288-2
– ident: B55
  doi: 10.33549/physiolres.934242
– ident: B6
  doi: 10.3389/fphys.2019.01607
– ident: B29
  doi: 10.1186/1475-2840-7-17
SSID ssj0014785
Score 2.381259
Snippet Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 309
SubjectTerms Adolescent
Adolescents
Advanced Oxidation Protein Products - blood
Biochemical analysis
Biomarkers - blood
Blood Pressure
Cell activation
Cell-Free Nucleic Acids - blood
Child
Cross-Sectional Studies
DNA damage
DNA, Mitochondrial - blood
Female
Fluorometry
Genomes
Humans
Inflammation
Innate immunity
Leukocytes (neutrophilic)
Male
Males
Metabolic syndrome
Metabolic Syndrome - blood
Metabolic Syndrome - epidemiology
Metabolic Syndrome - genetics
Mitochondrial DNA
Monocytes
Obesity
Oxidative stress
Prevalence
Regression Analysis
Risk Factors
Slovakia - epidemiology
Teenagers
Young Adult
Title Circulating extracellular DNA is in association with continuous metabolic syndrome score in healthy adolescents
URI https://www.ncbi.nlm.nih.gov/pubmed/34097532
https://www.proquest.com/docview/2558158515
https://www.proquest.com/docview/2539207392
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1531-2267
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0014785
  issn: 1094-8341
  databaseCode: KQ8
  dateStart: 19990701
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1531-2267
  dateEnd: 20241028
  omitProxy: true
  ssIdentifier: ssj0014785
  issn: 1094-8341
  databaseCode: DIK
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIqAXBOXRQEGLxK0y1N6H7WNJgD5ED6iVerPWu7ZkldhR4kRq_wp_lpm113FKIxUuVuT1-rHfl_HMevYbQj5qFYZRHnAvNizwuMx8L06V8A7STGjAXxk74fbjTB5d8JNLcTkY_O5lLS3q9JO-uXNdyf-gCvsAV1wl-w_IdieFHfAb8IUtIAzbe2E8Kmbalt-CcB-M7EzhNLzNKx2fHWKp8qLcV6vx7_LMocMCU18nWQ0cQJlrJ1ywP0dZS-zXLJC8vi355BxZmznaGU5Uep308uZHWF3nr_TfE1VWy8K6r-NqaT_R-3gQ7vkSL9Je2tD3BVjiq9UhP5VRZdd6WgFz-2c4XrrWdgIj8LtkV3j_OKPre-AGhn2r3EgIt-wLeyaWWTmFO0y_QCnZafP07rFRnjLA9UjNMuweJ6YTSwqGel-inWJdF952TQ_IwwBeGVgXZHx82n2i4mEkWhVbuPTnzRfeJo_dqdadnw0RjfVszp-Rp21IQg8bfj0ng6zcIY-aIqXXO-TJyNUEfEGqHuPoGuMoMI4Wc1qUtMc4ioyjK8bRjnHUMY5axmG_lnG0x7iX5OLb1_PRkdeW7PA042Ht-YqHTIWR0ikKBXKTHnBpdCxS30hhZKCVNr4BsFUupcqYMUrBWyCPo9wIGbFXZKusymyXUBmBZxv5Is90yhW4pTljQSSZzHjgp3kwJLEby0S3evZYVuVXYuNaESS3IEksJAlCMiSs6zttVF3u1WvPQZa0VmCeQEgONwlxixiSD10zwILjr8oMxhaOgSgEP4nDTb9uoO4u66jxZmPLW7K9-tvska16tsjegSdcp-8tI_8Af5O4iw
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circulating+extracellular+DNA+is+in+association+with+continuous+metabolic+syndrome+score+in+healthy+adolescents&rft.jtitle=Physiological+genomics&rft.au=Celec%2C+Peter&rft.au=Janovi%C4%8Dov%C3%A1%2C+%C4%B9ubica&rft.au=Gureck%C3%A1%2C+Radana&rft.au=Koborov%C3%A1%2C+Ivana&rft.date=2021-07-01&rft.eissn=1531-2267&rft.volume=53&rft.issue=7&rft.spage=309&rft_id=info:doi/10.1152%2Fphysiolgenomics.00029.2021&rft_id=info%3Apmid%2F34097532&rft.externalDocID=34097532
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1094-8341&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1094-8341&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1094-8341&client=summon